|
Sign In to gain access to subscriptions and/or personal tools.
|
First published on May 16, 2008, doi:10.1177/0883073808317726
Journal of Child Neurology 2008;23:1036.
A more recent version of this article appeared on September 1, 2008
Attitudes Toward Attention-Deficit Hyperactivity Disorder (ADHD) Treatment: Parents' and Children's Perspectives
Itai Berger, MD1*,
Talia Dor, MD1,
Yoram Nevo, MD1,
and
Gil Goldzweig, PhD2
1 Neuro-Pediatric Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
2 Department of Psychology, Hebrew University, Jerusalem, Israel
* To whom correspondence should be addressed. E-mail: itberg{at}hadassah.org.il.
 |
Abstract |
|---|
Attitudes toward pharmacological treatment may be a major factor contributing to adherence to such treatment. In the current study, attitudes toward methylphenidate treatment among 50 children diagnosed with attention-deficit hyperactivity disorder (ADHD) and their parents were assessed. Authors of this study have found that the study population is concerned and suspicious toward methylphenidate treatment. Most participants were exposed to negative information even before treatment initiation, which caused many participants to consult other sources and postpone the treatment initiation. Although experiencing methylphenidate as safe and effective (after 23.5 months of treatment), the leading cause of negative attitudes is the concern regarding long-term effects. The single most effective factor regarding the attitude toward methylphenidate treatment is the neurologists explanation. It is concluded that the pediatric neurologist has a crucial role in affecting attitudes of children and parents toward methylphenidate treatment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|